99006194 - MOVEMENTUM

Information

• Trademark
• 99006194

• Source

• Serial Number

  99006194

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  January 17, 2025
  4 months ago

• Transaction Date

  January 17, 2025
  4 months ago

• Status Date

  January 17, 2025
  4 months ago

• Location Date

  January 17, 2025
  4 months ago

• Status Code

  630

• Attorney Docket Number

  039011.00002

  Attorney Name

  Rebecca Dalton

• Owners

  • PRIMUS PHARMACEUTICALS, INC.

Case File Statements

• GS0051: Foods For Special Dietary Use; Pharmaceutical preparations for the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Vitamin preparations; Pharmaceutical preparations for restoring and maintaining health and function in the presence of pain, physical discomfort, stiffness, sensitization, energy, arterial, venous, circulatory, cognitive, mental, central nervous system, autoimmune and mobility limitations; Pharmaceutical preparations for the treatment and management of pain, physical discomfort, sensitization, energy, arterial, venous, circulatory, stiffness, and mobility limitations; Nutritional Supplements; Pharmaceutical preparations for the treatment, management, and maintenance of physical function in neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Dietary Supplements; Medical Foods; Foods specially formulated for functional, medical, dietary, distinctive nutritional requirement, health, and wellness uses; Pharmaceutical preparations for the treatment, prevention, and management of neurological, musculoskeletal, fibromyalgia, cardiovascular, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Foods specially formulated for medical use as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments; Foods specially formulated for medical use in the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Pharmaceutical preparations as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments

Case File Event Statements

• 1/17/2025 - 4 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/17/2025 - 4 months ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 1/17/2025 - 4 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS